Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and levodopa

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(levodopa)		Trials
(levodopa)		Recent Studies (post-2010) (levodopa)
6383124317,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomygadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baum, RP; Bonomo, L; Carreras, C; Castaldi, P; De Gaetano, AM; Giordano, A; Hommann, M; Hörsch, D; Kaemmerer, D; Rufini, V; Treglia, G1

Reviews

1 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and levodopa

ArticleYear
Role of PET/CT in the functional imaging of endocrine pancreatic tumors.
    Abdominal imaging, 2012, Volume: 37, Issue:6

    Topics: Cell Differentiation; Contrast Media; Dopamine Agents; Heterocyclic Compounds; Humans; Levodopa; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Peptide Hormones; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed

2012